Hemanext Inc. Receives CE Mark Certification for Innovative Red Blood Cell (RBC) Processing & Storage System - Seite 4

¹ HemanextONE, Instructions for Use (April 2021).
² Whitley et al. ISBT 2018 [Meeting Abstract].
³ D'Alessandro et al. Transfusion 2020;9999:1-13., Yoshida et al. Blood Transfus 2019;17:27-52.
⁴ D'Alessandro et al. Transfusion 2020;60:786-798.
⁵ D'Alessandro et al. Transfusion 2020;60:786-798., Yoshida et al. Blood Transfus 2019; 17(1):27-52.
⁶ D'Alessandro et al. Transfusion 2020;60:786-798., Yoshida et al. Blood Transfus 2019; 17(1):27-52.
⁷ Stegenga KA, Ward-Smith P, Hinds PS, et al. Quality of life among children with sickle cell disease receiving chronic transfusion therapy. J Pediatr Oncol Nurs 2004; 21 (4): 207-13.
⁸ Platzbecker U, Hofbauer LC, Ehninger G, et al. The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes. Leukemia Research 2012; 36(5): 525-36.
⁹ Jansen AJ, Essink-Bot ML, Beckers EA, et al. Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes. Br J Haematol 2003; 121 (2): 270-4.
¹⁰ Howard. Hematology Am Soc Hematol Educ Program. 2016; 2016(1):625-631., Galanello et al. Orphanet J Rare Dis. 2010; 5:11., Bennett. Am J Hematol. 2008; 83(11):858-61.
¹¹ Data on file, Hemanext, Inc.

Logo - https://mma.prnewswire.com/media/1486352/Hemanext_Logo.jpg